DK106147C - Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf.

Info

Publication number
DK106147C
DK106147C DK110364AA DK110364A DK106147C DK 106147 C DK106147 C DK 106147C DK 110364A A DK110364A A DK 110364AA DK 110364 A DK110364 A DK 110364A DK 106147 C DK106147 C DK 106147C
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
aminoquinoline compounds
aminoquinoline
Prior art date
Application number
DK110364AA
Other languages
Danish (da)
English (en)
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Application granted granted Critical
Publication of DK106147C publication Critical patent/DK106147C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/46Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DK110364AA 1961-12-29 1961-12-21 Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf. DK106147C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR883457 1961-12-29
FR891650 1962-03-20

Publications (1)

Publication Number Publication Date
DK106147C true DK106147C (da) 1966-12-27

Family

ID=26193748

Family Applications (2)

Application Number Title Priority Date Filing Date
DK110364AA DK106147C (da) 1961-12-29 1961-12-21 Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf.
DK558762AA DK106146C (da) 1961-12-29 1962-12-21 Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK558762AA DK106146C (da) 1961-12-29 1962-12-21 Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf.

Country Status (11)

Country Link
US (1) US3196155A (de)
AT (1) AT242141B (de)
BE (1) BE626239A (de)
CH (1) CH453360A (de)
DE (2) DE1156803B (de)
DK (2) DK106147C (de)
ES (1) ES280829A1 (de)
FR (3) FR42M (de)
GB (1) GB986350A (de)
LU (1) LU41571A1 (de)
NL (1) NL106667C (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515947A (en) * 1982-08-11 1985-05-07 Eastman Kodak Company Cyanoalkylpiperazines and methods for their preparation and use
US5182387A (en) * 1991-10-30 1993-01-26 Merrell Dow Pharmaceuticals Inc. Bis-dibenzoazepine compounds
EP2030967A1 (de) * 2007-08-31 2009-03-04 Sika Technology AG Hydroxylgruppen aufweisende Aldimine und Aldimin enthaltende Zusammensetzungen
EP3971178A1 (de) 2012-03-07 2022-03-23 The McLean Hospital Corporation Aminochinolinderivate und verwendungen davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1012751A (fr) * 1949-01-24 1952-07-17 Rhone Poulenc Sa Nouveau dérivé de la pipérazine et de la quinoléïne et son procédé de préparation
US2901484A (en) * 1957-03-04 1959-08-25 Abbott Lab Bis-quinoliniums
US3020283A (en) * 1958-10-20 1962-02-06 Abbott Lab Bis-lepidines

Also Published As

Publication number Publication date
CH453360A (fr) 1968-06-14
FR42M (de) 1960-11-28
NL106667C (de) 1900-01-01
AT242141B (de) 1965-08-25
GB986350A (en) 1965-03-17
US3196155A (en) 1965-07-20
FR82307A (de) 1900-01-01
BE626239A (de) 1900-01-01
FR82308A (de) 1900-01-01
DE1156803B (de) 1963-11-07
ES280829A1 (es) 1963-01-16
DE1196202B (de) 1965-07-08
DK106146C (da) 1966-12-27
LU41571A1 (de) 1962-06-19

Similar Documents

Publication Publication Date Title
DK107029C (da) Fremgangsmåde til fremstilling af substituerede 2-arylamino-1,3-diazacycloalkener eller syreadditionssalte deraf.
DK114903B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK104460C (da) Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.
DK114840B (da) Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf.
DK109779C (da) Fremgangsmåde til fremstilling af 3-aminopyrazinamidoguanidinforbindelser eller syreadditionssalte heraf.
DK103079C (da) Fremgangsmåde til fremstilling af 4-amino-quinolinforbindelser eller syreadditionssalte deraf.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK105205C (da) Fremgangsmåde til fremstilling af pyridyl- eller pyrazyloxyalkylaminoalkylaminer eller syreadditionssalte heraf.
DK108978C (da) Fremgangsmåde til fremstilling af phenylalkylaminer eller syreadditionssalte deraf.
DK106147C (da) Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf.
DK103672C (da) Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf.
DK103941C (da) Fremgangsmåde til fremstilling af 3-thiocarbamoyl-phenthiazinforbindelser eller syreadditionssalte deraf.
DK103017C (da) Fremgangsmåde til fremstilling af basisk substituerede dibenzocycloheptadien- eller dibenzocycloheptatrienforbindelser eller syreadditionssalte deraf.
DK104937C (da) Fremgangsmåde til fremstilling af imidazolidinon- eller imidazolidinthioforbindelser eller syreadditionssalte deraf.
DK103023C (da) Fremgangsmåde til fremstilling af 5-aryl-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK110091C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkylaminer eller syreadditionssalte heraf.
DK102807C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkenylaminer eller syreadditionssalte heraf.
DK118189B (da) Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf.
DK129714B (da) Fremgangsmåde til fremstilling af benzimidazolinoner eller syreadditionssalte deraf.
DK104513C (da) Fremgangsmåde til fremstilling af tetraethoxybenzal-tetrahydro-isoquinolinderivater eller syreadditionssalte deraf.
DK105067C (da) Fremgangsmåde til fremstilling af benzimidazolforbindelser eller syreadditionssalte deraf.
DK101301C (da) Fremgangsmåde til fremstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf.
DK102575C (da) Fremgangsmåde til fremstilling af N-benzodioxylurethaner eller syreadditionssalte heraf.
DK101066C (da) Fremgangsmåde til fremstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf.
DK99268C (da) Fremgangsmåde til fremstilling af aminobenzoksacykloalkaner eller syreadditionssalte deraf.